混合内皮心疗法用于高级心房动
Christopher X Wong1,2, Eric F Buch3, Ramin Beygui4
1Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide 5001, Australia.
Journal of clinical medicine
|February 10, 2024
概括
心房动 (AF) 的管理正在发展. 混合废弃疗法为晚期AF患者提供了改善的长期结果,可能成为一线治疗.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 心房动 (AF) 是一种普遍的疾病,与增加的发病率和死亡率有关.
- 肌前膜炎的进展会导致疾病的晚期,传统的内心脏切除会显示出低于最佳的结果.
- 了解AF进展和风险因素对于开发有效的治疗方法至关重要.
研究的目的:
- 审查心房的机制,危险因素和进展情况.
- 为了评估混合废弃疗法在先进的AF疗法的疗效.
- 探索混合内皮心切除作为一线治疗的潜力.
主要方法:
- 审查关于AF机制,风险因素和进展的最新研究.
- 对早期内心导管切除结果的分析与先进的AF.
- 检查混合废弃疗法和协作护理模型的开发和采用情况.
主要成果:
- 心内膜切除在早期的性肌痛前列腺炎中是有效的,但在晚期的肌痛前列腺炎中效果较差.
- 混合废除疗法,结合协作护理,改善了先进的AF中长期无心律生存率.
- 混合疗法是患者的有前途的选择非帕洛克斯 AF,心房改造,或并发症.
结论:
- 混合除疗法在治疗复杂和高级心房动方面取得了重大进展.
- 协作的心脏护理团队提高了难以治疗的AF的治疗成功率.
- 进一步研究混合内皮心切除是有必要的,以确定其作为主要治疗策略的作用.
更多相关视频
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


